Sangamo Therapeutics, Inc.: Sangamo Therapeutics to Present Pre-clinical Data From Its Genomic Engineering Platform at the 26th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the American Society of Gene Cell Therapy (ASGCT) has accepted 14 Sangamo abstracts for presentation at the
Louise Wilkie Jason Fontenot Los Angeles Platform Development For Production Administration In Cynomolgus Macaques Sangamo Therapeutics Inc
Source: finanznachrichten.de